These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 23450565)
1. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. De Caluwé L; Van Nieuwenhove Y; Ceelen WP Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006041. PubMed ID: 23450565 [TBL] [Abstract][Full Text] [Related]
2. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer. Ceelen WP; Van Nieuwenhove Y; Fierens K Cochrane Database Syst Rev; 2009 Jan; (1):CD006041. PubMed ID: 19160264 [TBL] [Abstract][Full Text] [Related]
3. Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis. Ceelen W; Fierens K; Van Nieuwenhove Y; Pattyn P Int J Cancer; 2009 Jun; 124(12):2966-72. PubMed ID: 19253365 [TBL] [Abstract][Full Text] [Related]
5. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. Abraha I; Aristei C; Palumbo I; Lupattelli M; Trastulli S; Cirocchi R; De Florio R; Valentini V Cochrane Database Syst Rev; 2018 Oct; 10(10):CD002102. PubMed ID: 30284239 [TBL] [Abstract][Full Text] [Related]
6. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Wong RK; Tandan V; De Silva S; Figueredo A Cochrane Database Syst Rev; 2007 Apr; (2):CD002102. PubMed ID: 17443515 [TBL] [Abstract][Full Text] [Related]
7. Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data. Fiorica F; Cartei F; Licata A; Enea M; Ursino S; Colosimo C; Cammà C Cancer Treat Rev; 2010 Nov; 36(7):539-49. PubMed ID: 20334979 [TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy versus single-agent chemotherapy during preoperative chemoradiation for resectable rectal cancer. Resende HM; Jacob LFP; Quinellato LV; Matos D; da Silva EM Cochrane Database Syst Rev; 2015 Oct; 10(10):CD008531. PubMed ID: 35658163 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer. Ceelen W; Boterberg T; Pattyn P; van Eijkeren M; Gillardin JM; Demetter P; Smeets P; Van Damme N; Monsaert E; Peeters M Ann Surg Oncol; 2007 Feb; 14(2):424-31. PubMed ID: 17096057 [TBL] [Abstract][Full Text] [Related]
10. Alternative clinical end points in rectal cancer--are we getting closer? Glynne-Jones R; Mawdsley S; Pearce T; Buyse M Ann Oncol; 2006 Aug; 17(8):1239-48. PubMed ID: 16873440 [TBL] [Abstract][Full Text] [Related]
11. Treatment of newly diagnosed glioblastoma in the elderly: a network meta-analysis. Hanna C; Lawrie TA; Rogozińska E; Kernohan A; Jefferies S; Bulbeck H; Ali UM; Robinson T; Grant R Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013261. PubMed ID: 32202316 [TBL] [Abstract][Full Text] [Related]
12. Stage-to-stage comparison of preoperative and postoperative chemoradiotherapy for T3 mid or distal rectal cancer. Yeo SG; Kim DY; Park JW; Choi HS; Oh JH; Kim SY; Chang HJ; Kim TH; Sohn DK Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):856-62. PubMed ID: 21300482 [TBL] [Abstract][Full Text] [Related]
13. Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials. Song JH; Jeong JU; Lee JH; Kim SH; Cho HM; Um JW; Jang HS; Radiat Oncol J; 2017 Sep; 35(3):198-207. PubMed ID: 29037017 [TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant treatments for resectable rectal cancer: A network meta-analysis. Zhong W; Xue X; Dai L; Li R; Nie K; Zhou S Exp Ther Med; 2020 Apr; 19(4):2604-2614. PubMed ID: 32256740 [TBL] [Abstract][Full Text] [Related]
15. Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial. Lee JB; Kim HS; Jung I; Shin SJ; Beom SH; Chang JS; Koom WS; Kim TI; Hur H; Min BS; Kim NK; Park S; Jeong SY; Baek JH; Kim SH; Lim JS; Lee KY; Ahn JB Trials; 2020 Apr; 21(1):320. PubMed ID: 32264919 [TBL] [Abstract][Full Text] [Related]
17. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer. Kokka F; Bryant A; Brockbank E; Powell M; Oram D Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525 [TBL] [Abstract][Full Text] [Related]
18. Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical Trial. Li N; Zhu Y; Liu LY; Feng YR; Wang WL; Wang J; Wang H; Li GF; Tang Y; Hu C; Liu WY; Ren H; Wang SL; Wang WH; Song YW; Liu YP; Fang H; Tang Y; Lu NN; Chen B; Qi SN; Liu XF; Li YX; Jin J JAMA Netw Open; 2021 Nov; 4(11):e2136116. PubMed ID: 34846525 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Preoperative Radiotherapy Versus Chemoradiotherapy in Advanced Rectal Cancer: A Meta-analysis of Randomized Controlled Trials. Yu M; Wang DC; Li S; Huang LY; Wei J Am Surg; 2023 Jun; 89(6):2262-2271. PubMed ID: 35435026 [TBL] [Abstract][Full Text] [Related]
20. Preoperative conventional chemoradiotherapy versus short-course radiotherapy with delayed surgery for rectal cancer: results of a randomized controlled trial. Latkauskas T; Pauzas H; Kairevice L; Petrauskas A; Saladzinskas Z; Janciauskiene R; Gudaityte J; Lizdenis P; Svagzdys S; Tamelis A; Pavalkis D BMC Cancer; 2016 Dec; 16(1):927. PubMed ID: 27903247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]